๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
Flonoltinib Maleate (FM) targets Janus kinase 2 (JAK2) and FMS-like tyrosin...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-11-12
Trial ID
NCT05115344
The goal of this clinical trial is to learn which of three different doses ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-11
Trial ID
NCT07750574
Treatments Being Tested
Flonoltinib Maleate (FM) is a triple-target inhibitor of JAK2, FLT3, and CD...
Status
Terminated
Location
Chengdu Zenitar Biomedical Technology Co., Ltd
Start Date
2023-05-23
Trial ID
NCT05713279
Treatments Being Tested
A Randomized, Open-Label, Two-Period, Two-Crossover Study to Evaluate the E...
Status
Completed
Location
Chengdu Xinhua Hospital
Start Date
2024-08-04
Trial ID
NCT07193576
Treatments Being Tested
This trial adopts a multicenter, open-label, positive drug parallel control...
Status
Active Not Recruiting
Location
West China Hospital Sichuan University
Start Date
2024-05-06
Trial ID
NCT06457425
Treatments Being Tested
Flonoltinib Maleate (FM) targets Janus kinase 2 (JAK2) and FMS-like tyrosin...
Status
Completed
Location
West China Hospital Sichuan University
Start Date
2021-12-27
Trial ID
NCT05153343
Treatments Being Tested
This trial adopts an open, randomized, parallel controlled, multicenter cli...
Status
Recruiting
Location
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS)
Start Date
2025-09-23
Trial ID
NCT07232290
Treatments Being Tested
Evaluate the safety , tolerability and pharmacokinetics of Flonoltinib Male...
Status
Completed
Location
Chengdu Xinhua Hospital
Start Date
2024-03-18
Trial ID
NCT06387966
Treatments Being Tested
This study is a single center, open label, fixed sequence drug interaction ...
Status
Not Yet Recruiting
Location
The Second Affiliated Hospital of Anhui Medical University
Start Date
2026-10-30
Trial ID
NCT07768111
Treatments Being Tested